Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial-论文-万方医学网

首页> > Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial

Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial

导出原文传递

翻译打印收藏纠错

第一作者： Jingying Wu

作者： Jingying Wu ^[1] ; Renpeng Zhou ; Qian Zhang ; Qin Zhang ; Huiling Qin ; Zi Ye ; Yimei Xu ; Sheng Feng ; Chang Shu ; Yu Shen ; Yang Fan ; Quanren Wang ; Yijun Du ; Wei Hu

作者单位： Endocrinology Unit, Shaare Zedek Medical CentreHebrew University of Jerusalem The Faculty of ^[1]

关键词 food effect glucagon‐like peptide‐1 receptor antagonist healthy participants HRS‐7535 pharmacodynamics pharmacokinetics safety

发布时间 2024-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial

相似文献

同项目论文

相关期刊

检索历史 清除

Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial

相似文献

同项目论文

相关期刊

检索历史清除